Thermo Fisher Scientific Inc. (TMO)
NYSE: TMO · Real-Time Price · USD
514.16
-5.74 (-1.10%)
Mar 25, 2025, 4:00 PM EST - Market closed
Thermo Fisher Revenue
In the year 2024, Thermo Fisher had annual revenue of $42.88B with 0.05% growth. Thermo Fisher had revenue of $11.40B in the quarter ending December 31, 2024, with 4.68% growth.
Revenue (ttm)
$42.88B
Revenue Growth
+0.05%
P/S Ratio
4.63
Revenue / Employee
$343,032
Employees
125,000
Market Cap
193.97B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 42.88B | 22.00M | 0.05% |
Dec 31, 2023 | 42.86B | -2.06B | -4.58% |
Dec 31, 2022 | 44.92B | 5.70B | 14.55% |
Dec 31, 2021 | 39.21B | 6.99B | 21.71% |
Dec 31, 2020 | 32.22B | 6.68B | 26.14% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Abbott Laboratories | 41.95B |
TMO News
- 7 days ago - Thermo Fisher Scientific Introduces the Vulcan™ Automated Lab to Transform Semiconductor Analysis - Business Wire
- 17 days ago - Buy Two Ideal March 'Safer' Dividend Dogs Of 34 Barron's 2025 Pro-Picks - Seeking Alpha
- 18 days ago - Thermo Fisher Scientific: Strong Q4, Strategic M&A, And Poised For Growth In Life Sciences - Seeking Alpha
- 22 days ago - Thermo Fisher Scientific Inc. (TMO) TD Cowen 45th Annual Health Care Conference - (Transcript) - Seeking Alpha
- 27 days ago - Trian Comments on Solventum's Sale of its Purification & Filtration Business - GlobeNewsWire
- 27 days ago - Thermo Fisher Scientific Launches CorEvitas Clinical Registry and Biorepository in Systemic Lupus Erythematosus - Business Wire
- 4 weeks ago - Thermo Fisher buys Solventum's purification and filtration business for $4.1 billion - Reuters
- 4 weeks ago - Solventum Announces Sale of its Purification & Filtration Business to Thermo Fisher Scientific Inc. for $4.1B - PRNewsWire